Clinical use and monitoring of adverse effects of sodium‐glucose cotransporter‐2 inhibitors in persons with type 1 diabetes mellitus

Clinical use and monitoring of adverse effects of sodium‐glucose cotransporter‐2 inhibitors in persons with type 1 diabetes mellitus

ABSTRACT Aims This study aimed to evaluate the factors contributing to insulin dosage adjustment and the risk of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) discontinuation in persons with type 1 diabetes mellitus (T1DM) starting SGLT2i therapy in clinical practice. Materials and Methods This...

Full description

Saved in:
Bibliographic Details
Main Authors: Chinatsu Sakai, Shinichi Tamaru, Keiji Sugai, Hironori Takeuchi, Ryo Suzuki
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Journal of Diabetes Investigation
Subjects:
SGLT2 inhibitors
Side effect
Type 1 diabetes mellitus
Online Access:https://doi.org/10.1111/jdi.70085
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items